Florida Senate - 2015                        COMMITTEE AMENDMENT
       Bill No. SB 566
       
       
       
       
       
       
                                Ì888378dÎ888378                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  03/30/2015           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Commerce and Tourism (Richter) recommended the
       following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Delete lines 303 - 314
    4  and insert:
    5         Section 9. Paragraphs (g) and (m) of subsection (8) of
    6  section 499.012, Florida Statutes, are amended to read:
    7         499.012 Permit application requirements.—
    8         (8) An application for a permit or to renew a permit for a
    9  prescription drug wholesale distributor or an out-of-state
   10  prescription drug wholesale distributor submitted to the
   11  department must include:
   12         (g)1. For an application for a new permit, the estimated
   13  annual dollar volume of prescription drug sales of the
   14  applicant, the estimated annual percentage of the applicant’s
   15  total company sales that are prescription drugs, the applicant’s
   16  estimated annual total dollar volume of purchases of
   17  prescription drugs, and the applicant’s estimated annual total
   18  dollar volume of prescription drug purchases directly from
   19  manufacturers.
   20         2. For an application to renew a permit, the total dollar
   21  volume of prescription drug sales in the previous year, the
   22  total dollar volume of prescription drug sales made in the
   23  previous 6 months, the percentage of total company sales that
   24  were prescription drugs in the previous year, the total dollar
   25  volume of purchases of prescription drugs in the previous year,
   26  and the total dollar volume of prescription drug purchases
   27  directly from manufacturers in the previous year.
   28         3. Such portions of the information required pursuant to
   29  this paragraph which are a trade secret, as defined in s.
   30  812.081, shall be maintained by the department as trade secret
   31  information is required to be maintained under s. 499.051. This
   32  subparagraph is subject to the Open Government Sunset Review Act
   33  in accordance with s. 119.15 and shall stand repealed on October
   34  2, 2020, unless reviewed and saved from repeal through
   35  reenactment by the Legislature.
   36         (m) For an applicant that is a secondary wholesale
   37  distributor, each of the following:
   38         1. A personal background information statement containing
   39  the background information and fingerprints required pursuant to
   40  subsection (9) for each person named in the applicant’s response
   41  to paragraphs (k) and (l) and for each affiliated party of the
   42  applicant.
   43         2. If any of the five largest shareholders of the
   44  corporation seeking the permit is a corporation, the name,
   45  address, and title of each corporate officer and director of
   46  each such corporation; the name and address of such corporation;
   47  the name of such corporation’s resident agent, such
   48  corporation’s resident agent’s address, and such corporation’s
   49  state of its incorporation; and the name and address of each
   50  shareholder of such corporation that owns 5 percent or more of
   51  the stock of such corporation.
   52         3.a. The name and address of all financial institutions in
   53  which the applicant has an account which is used to pay for the
   54  operation of the establishment or to pay for drugs purchased for
   55  the establishment, together with the names of all persons that
   56  are authorized signatories on such accounts.
   57         b. The portions of the information required pursuant to
   58  this subparagraph which are a trade secret, as defined in s.
   59  812.081, shall be maintained by the department as trade secret
   60  information is required to be maintained under s. 499.051. This
   61  sub-subparagraph is subject to the Open Government Sunset Review
   62  Act in accordance with s. 119.15 and shall stand repealed on
   63  October 2, 2020, unless reviewed and saved from repeal through
   64  reenactment by the Legislature.
   65         4. The sources of all funds and the amounts of such funds
   66  used to purchase or finance purchases of prescription drugs or
   67  to finance the premises on which the establishment is to be
   68  located.
   69         5. If any of the funds identified in subparagraph 4. were
   70  borrowed, copies of all promissory notes or loans used to obtain
   71  such funds.
   72         Section 10. Subsection (7) of section 499.0121, Florida
   73  Statutes, is amended to read:
   74         499.0121 Storage and handling of prescription drugs;
   75  recordkeeping.—The department shall adopt rules to implement
   76  this section as necessary to protect the public health, safety,
   77  and welfare. Such rules shall include, but not be limited to,
   78  requirements for the storage and handling of prescription drugs
   79  and for the establishment and maintenance of prescription drug
   80  distribution records.
   81         (7) PRESCRIPTION DRUG PURCHASE LIST.—
   82         (a) Each wholesale distributor, except for a manufacturer,
   83  shall annually provide the department with a written list of all
   84  wholesale distributors and manufacturers from whom the wholesale
   85  distributor purchases prescription drugs. A wholesale
   86  distributor, except a manufacturer, shall notify the department
   87  not later than 10 days after any change to either list.
   88         (b) Such portions of the information required pursuant to
   89  this subsection which are a trade secret, as defined in s.
   90  812.081, shall be maintained by the department as trade secret
   91  information is required to be maintained under s. 499.051. This
   92  paragraph is subject to the Open Government Sunset Review Act in
   93  accordance with s. 119.15 and shall stand repealed on October 2,
   94  2020, unless reviewed and saved from repeal through reenactment
   95  by the Legislature.
   96         Section 11. Subsection (7) of section 499.051, Florida
   97  Statutes, is amended to read:
   98         499.051 Inspections and investigations.—
   99         (7)(a) The complaint and all information obtained pursuant
  100  to the investigation by the department are confidential and
  101  exempt from s. 119.07(1) and s. 24(a), Art. I of the State
  102  Constitution until the investigation and the enforcement action
  103  are completed.
  104         (b)Information that constitutes a However, trade secret,
  105  as defined in s. 812.081, information contained in the complaint
  106  therein as defined by s. 812.081(1)(c) shall
  107  
  108  ================= T I T L E  A M E N D M E N T ================
  109  And the title is amended as follows:
  110         Delete lines 4 - 16
  111  and insert:
  112         403.7046, 403.73, 499.012, 499.0121, 499.051, 502.222,
  113         570.48, 573.123, 601.10, 601.15, 601.152, 601.76, and
  114         815.04, F.S.; expanding public records exemptions for
  115         certain data processing software obtained by an
  116         agency, certain information held by a county tourism
  117         promotion agency, information related to trade secrets
  118         held by the Florida Tourism Industry Marketing
  119         Corporation, information related to trade secrets held
  120         by Space Florida, proprietary confidential business
  121         information submitted to the Department of Revenue,
  122         trade secret information held by the Department of
  123         Health, trade secret information reported or submitted
  124         to the Department of Environmental Protection, trade
  125         secret information in an application for a permit for
  126         a prescription drug wholesale distributor or an out
  127         of-state prescription drug wholesale distributor,
  128         trade secret information contained in an application
  129         for a permit for a secondary wholesale distributor,
  130         trade secret information contained in the prescription
  131         drug purchase list, trade secret